PASW
Ping An Biomedical Co., Ltd.
There isn't enough reported data to score PASW yet.
PASW Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Weak | |
| Unavailable | |
| Unavailable |
PASW's profitability is currently weak. There isn't enough data to rate its revenue, cash flow and balance sheet.
PASW PE Valuation
PASW has no meaningful PE right now: it lost money over the past year.
PASW Forward outlook
There aren't enough analyst estimates for PASW to show an outlook.
PASW Earnings Per Share
PASW Quarterly Revenue
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2025 | -70% | N/A |
| Q1 2025 | -20% | N/A |
PASW Free Cash Flow
PASW Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +2.7% | +12K shares |
PASW Net Leverage
PASW's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
PASW Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 13.7 | Oversold |
| Stochastic | 13.3 | Oversold |
PASW's weekly RSI is 14 (oversold) and its Stochastic is 13 (oversold).
PASW PE vs Industrials Sector
PASW has no meaningful PE right now: it lost money over the past year.
PASW Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $4.06 | 62% below |
| 20 week MA | $4.89 | 68% below |
| 50 week MA | $7.60 | 79% below |
PASW is in a downtrend: it's below all three of its weekly moving averages, and 79% below its 50-week average.
PASW Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $132.0 | $25.5 | -81% |
| 2026 YTD | $25.5 | $1.56 | -94% |
PASW has finished every year since 2025 lower, and it's down 94% so far in 2026.